Literature DB >> 19452299

Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer.

T Padma Priya1, V K Kapoor, Narendra Krishnani, Vinita Agrawal, Suraksha Agarwal.   

Abstract

OBJECTIVE: Present study deals with LOH and MSI in FHIT gene and p53 expression in GBC, CC, XGC, and normal GB to elucidate the role of FHIT gene in gall bladder cancer.
METHODS: Five microsatellite markers D3S1217, D3S1300, D3S1313, D3S1600, and D3S2757, were selected.
RESULTS: Among GBC cases the frequency of MSI-H and LOH was 17.5% and 27.5%, respectively. Significant difference was found between GBC and normal GB (p = .02), and GBC and CC groups (p= .002) when LOH was compared.
CONCLUSIONS: Our results suggested CC might act as a preinvasive stage in the pathogenesis of GBC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19452299     DOI: 10.1080/07357900802711304

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  4 in total

Review 1.  Xanthogranulomatous cholecystitis: a European and global perspective.

Authors:  Matthew David Hale; Keith J Roberts; James Hodson; Nigel Scott; Maria Sheridan; Giles J Toogood
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

2.  Role of E-cadherin gene in gall bladder cancer and its precursor lesions.

Authors:  T Padma Priya; V K Kapoor; N Krishnani; Vinita Agrawal; Suraksha Agrawal
Journal:  Virchows Arch       Date:  2010-04-08       Impact factor: 4.064

Review 3.  Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.

Authors:  Aarti Sharma; Kiran Lata Sharma; Annapurna Gupta; Alka Yadav; Ashok Kumar
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

Review 4.  Genetic Polymorphism Predisposing to Differentiated Thyroid Cancer: A Review of Major Findings of the Genome-Wide Association Studies.

Authors:  Vladimir A Saenko; Tatiana I Rogounovitch
Journal:  Endocrinol Metab (Seoul)       Date:  2018-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.